Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Safety and efficacy of same-day discharge after gastric peroral endoscopic myotomy for gastroparesis: A systematic review and meta-analysis

2 months 1 week ago
CONCLUSIONS: This meta-analysis demonstrates no significant difference in outcomes between patients with same-day discharge vs. overnight admissions after G-POEM.
Aamir Saeed

Young adults' responses to e-cigarette advertisements: An examination for potential regulation

2 months 1 week ago
CONCLUSIONS: People and descriptive language captured the most attention in e-cigarette ads. Limiting testimonials, "switching" language, and restricting ads to branding-only formats may reduce appeal among young adults and help prevent initiation.
Elise M Stevens

Challenges and opportunities for treatment of medulloblastoma

2 months 1 week ago
Medulloblastoma (MB) stands out as the most prevalent, invasive, and biologically heterogeneous pediatric brain tumor. MB accounts for almost 1/4th of all intracranial neoplasms. The prime age of diagnosis is 5-9 years of age; however, the disease is also seen at a later age in approximately 25 % adults. The standard treatment for the disease is comprised of multimodal approaches incorporating surgery, radiation therapy, and adjuvant chemotherapy, which increases the survival to 70-80 %. Despite...
Meghna Mehta

Multimodality Imaging in Hypertrophic Cardiomyopathy

2 months 1 week ago
The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and...
Matthew Peters

Multimodality Imaging in Prosthetic Valve Dysfunction

2 months 1 week ago
Multimodality imaging plays a critical role in the evaluation of prosthetic valve function. Although echocardiography-both transthoracic and transesophageal-remains the first-line diagnostic tool, complementary imaging modalities such as cardiac computed tomography, cardiac MRI, and PET provide valuable additional information. Accurate assessment of prosthetic valve dysfunction often requires an integrative imaging approach owing to the complexity of structural and functional abnormalities. This...
Jeremiah Haines

Pagination

  • Previous page ‹ Previous
  • Page 62
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies